Open Access Green as soon as Postprint is submitted to ZB.
CD19-independent instruction of murine marginal zone B-cell development by constitutive Notch2 signaling.
Blood 118, 6321-6331 (2011)
B cell-specific gene ablation of Notch2 results in the loss of the Marginal Zone (MZ) B cell lineage. To analyze the effects of constitutive Notch2 signaling in B cells, we have generated a transgenic mouse strain allowing the conditional expression of a constitutively active, intracellular form of Notch2 (Notch2IC). Expression of Notch2IC at the earliest developmental stages of the B cell lineage completely abolished B cell generation and led to the development of ectopic T cells in the bone marrow, showing that Notch2IC is acting redundantly with Notch1IC in driving ectopic T cell differentiation. In B cells clearly committed to the B cell lineage induction of Notch2IC drove all cells towards the MZ B cell compartment at the expense of Follicular B cells. Notch2IC-expressing B cells reflected the phenotype of wild type MZ B cells with respect to their localization in the MZ, the expression of characteristic surface markers, their enhanced proliferation after stimulation and increased basal activity of Akt, Erk and Jnk. Notch2IC-driven MZ B cell generation in the spleen was achieved even in the absence of CD19. Our results implicate that a constitutive Notch2 signal in T1 B cells is sufficient to drive MZ B cell differentiation.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Times Cited
Scopus
Cited By
Cited By
Altmetric
10.558
2.337
30
59
Annotations
Special Publikation
Hide on homepage
Publication type
Article: Journal article
Document type
Scientific Article
Keywords
no keywords
Language
english
Publication Year
2011
HGF-reported in Year
2011
ISSN (print) / ISBN
0006-4971
e-ISSN
1528-0020
Journal
Blood
Quellenangaben
Volume: 118,
Issue: 14,
Pages: 6321-6331
Publisher
American Society of Hematology
Publishing Place
Washington, DC, USA
Reviewing status
Peer reviewed
Institute(s)
Research Unit Gene Vector (AGV)
Institute of Developmental Genetics (IDG)
CCG Molecular Oncology (AGV-KON)
Institute of Developmental Genetics (IDG)
CCG Molecular Oncology (AGV-KON)
POF-Topic(s)
30203 - Molecular Targets and Therapies
30204 - Cell Programming and Repair
30204 - Cell Programming and Repair
Research field(s)
Immune Response and Infection
Genetics and Epidemiology
Genetics and Epidemiology
PSP Element(s)
G-501500-003
G-500500-001
G-520700-001
G-500500-001
G-520700-001
PubMed ID
21795747
Scopus ID
83455196170
Erfassungsdatum
2011-11-08